Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $270.96 million. The enterprise value is $227.76 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 54.41 million shares outstanding. The number of shares has increased by 4.40% in one year.
| Current Share Class | 54.41M |
| Shares Outstanding | 54.41M |
| Shares Change (YoY) | +4.40% |
| Shares Change (QoQ) | +1.62% |
| Owned by Insiders (%) | 19.01% |
| Owned by Institutions (%) | 38.14% |
| Float | 35.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.41 |
| Forward PS | 3.06 |
| PB Ratio | 4.99 |
| P/TBV Ratio | 5.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.77.
| Current Ratio | 5.86 |
| Quick Ratio | 5.26 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.33 |
Financial Efficiency
Return on equity (ROE) is -56.64% and return on invested capital (ROIC) is -16.05%.
| Return on Equity (ROE) | -56.64% |
| Return on Assets (ROA) | -14.34% |
| Return on Invested Capital (ROIC) | -16.05% |
| Return on Capital Employed (ROCE) | -29.99% |
| Weighted Average Cost of Capital (WACC) | 16.30% |
| Revenue Per Employee | $427,704 |
| Profits Per Employee | -$200,280 |
| Employee Count | 186 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | -20,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.83% in the last 52 weeks. The beta is 2.37, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.37 |
| 52-Week Price Change | +51.83% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 5.18 |
| Relative Strength Index (RSI) | 58.57 |
| Average Volume (20 Days) | 363,889 |
Short Selling Information
The latest short interest is 936,889, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 936,889 |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 2.65% |
| Short Ratio (days to cover) | 2.69 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $79.55 million and -$37.25 million in losses. Loss per share was -$0.71.
| Revenue | 79.55M |
| Gross Profit | 68.55M |
| Operating Income | -27.45M |
| Pretax Income | -37.27M |
| Net Income | -37.25M |
| EBITDA | -27.01M |
| EBIT | -27.45M |
| Loss Per Share | -$0.71 |
Full Income StatementBalance Sheet
The company has $84.96 million in cash and $41.76 million in debt, with a net cash position of $43.20 million or $0.79 per share.
| Cash & Cash Equivalents | 84.96M |
| Total Debt | 41.76M |
| Net Cash | 43.20M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 53.90M |
| Book Value Per Share | 1.00 |
| Working Capital | 88.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.12 million and capital expenditures -$284,000, giving a free cash flow of -$25.40 million.
| Operating Cash Flow | -25.12M |
| Capital Expenditures | -284,000 |
| Depreciation & Amortization | 441,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.40M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
Gross margin is 86.17%, with operating and profit margins of -34.51% and -46.83%.
| Gross Margin | 86.17% |
| Operating Margin | -34.51% |
| Pretax Margin | -46.85% |
| Profit Margin | -46.83% |
| EBITDA Margin | -33.95% |
| EBIT Margin | -34.51% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.40% |
| Shareholder Yield | -4.40% |
| Earnings Yield | -13.75% |
| FCF Yield | -9.37% |
Analyst Forecast
The average price target for Sight Sciences is $8.34, which is 67.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.34 |
| Price Target Difference | 67.47% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.55 |
| Piotroski F-Score | 4 |
